Ubiquitination/ Proteasome(泛素化/蛋白酶体)
- Autophagy(1114)
- DUB(17)
- E1 Activating(1)
- E2 conjugating(1)
- E3 Ligase(7)
- Proteasome(69)
- p97(12)
- Mitophagy(82)
- ULK(9)
- Cat.No. 产品名称 Information
-
GC15605
Ezetimibe
依泽替米贝; SCH 58235
A cholesterol transport inhibitor -
GC13029
AZD2014
3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺,AZD 2014; AZD-2014
A potent dual mTORC1/2 inhibitor -
GC16526
Atropine
阿托品; Tropine tropate; DL-Hyoscyamine
A non-selective muscarinic acetylcholine receptor antagonist -
GC10710
3-Methyladenine
3-甲基腺嘌呤; 3-MA
3-甲基腺嘌呤是一种经典的自噬抑制剂。 -
GC12730
Pazopanib Hydrochloride
盐酸帕唑帕尼; GW786034 (Hydrochloride)
A multi-kinase inhibitor -
GC15455
VX-809
鲁玛卡托; VX-809; VRT 826809
A F508del-CFTR corrector -
GC13037
CX-4945 (Silmitasertib)
CX 4945;CX4945
A potent, orally bioavailable CK2 inhibitor -
GC14482
Verteporfin
维替泊芬; CL 318952
维替泊芬是一种有效的 PD-L1 表达抑制剂,用于治疗年龄相关性黄斑变性、鲜红斑痣和癌症。 -
GC10970
WP1130
WP 1130; WP-1130
A deubiquitinase inhibitor -
GC15904
PP242
PP242; PP-242
Potent inhibitor of mTOR kinase in both mTORC1 and mTORC2 -
GC12573
Temsirolimus
西罗莫司脂化物,Torisel;CCI-779;CCI 779;CCI779
A specific inhibitor of mTOR activity -
GC15818
RAF265
CHIR-265;RAF 265;RAF-265;CHIR265
A B-Raf and VEGFR2 inhibitor -
GC10131
Torin 1
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮,Torin1;Torin-1
Selective inhibitor of mTOR
-
GC15680
Perifosine
哌立福新; KRX-0401; NSC 639966; D21266
Perifosine 是 Akt 的抑制剂 。
-
GC10261
PH-797804
PH797804;PH 797804
A selective p38 MAPK inhibitor -
GC14906
Crenolanib (CP-868596)
[1-[2-[5-(3-甲基氧杂环丁烷-3-基甲氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基]胺,CP-868596;CP 868596;CP868596
An inhibitor of PDGFRα/β and FLT3 - GC16436 Tenovin-6 A small molecule activator of p53
-
GC12021
GDC-0349
N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲
A potent inhibitor of mTOR -
GC14920
VX-661
VX-661
An investigational compound that promotes the maturation of delta F508 CFTR -
GC10944
Butein
紫铆因; 2’,3,4,4’-tetrahydroxy Chalcone
A plant polyphenol -
GC11752
AZD5363
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺,AZD5363
A pan-Akt inhibitor -
GC10359
GANT61
2,2'-[[二氢-2-(4-吡啶基)-1,3(2H,4H)-嘧啶二基]二(亚甲基)]二[N,N-二甲基苯胺],NSC 136476
GANT61 能够有效阻断 GLI1 和 GLI2 诱导的转录,IC50 为 5 μM。 - GC10395 Dynasore Dynasore 作为 GTPase 抑制剂,可以快速、可逆地抑制发动蛋白活性,从而阻止内吞作用。
-
GC12843
MEK162 (ARRY-162, ARRY-438162)
贝美替尼,MEK162; ARRY-162; ARRY-438162
A MEK1/2 inhibitor -
GC10596
T0901317
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺
Selective agonist for LXRα and LXRβ -
GC17295
10058-F4
5-(4-乙基苯亚甲基)
10058-F4是一种c-Myc抑制剂,抑制c-Myc-Max二聚化,阻止c-Myc靶基因表达的转录激活。 - GC11015 PD168393 An irreversible EGFR kinase inhibitor
-
GC16380
AZD8055
CCG-168
AZD8055是一种新型的ATP竞争性mTOR抑制剂,IC50 为0.8 nmol/L,Ki为1.3 nmol/L。 -
GC17615
Quizartinib (AC220)
奎扎替尼; AC220
An inhibitor of FLT3 -
GC14289
Fasudil (HA-1077) HCl
盐酸法舒地尔; HA-1077 Hydrochloride; AT-877 Hydrochloride
Fasudil(法舒地尔;HA-1077;AT877)是一种非特异性RhoA/ROCK抑制剂,对ROCK1的Ki为0.33μM,IC50为0.158μM,对ROCK2和PKA、PKC、PKG的IC50分别为4.58μM、12.30μM、1.650μM。 -
GC11497
BIRB 796 (Doramapimod)
达马莫德; BIRB 796
A potent inhibitor of p38 MAPK -
GC16835
LY2228820
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐,LY2228820 dimesylate
A potent inhibitor of p38α MAP kinase -
GC16851
AZD6482
2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸,KIN-193
A PI3Kβ inhibitor -
GC14574
Tigecycline
替加环素; GAR-936
A glycylcycline antibiotic -
GC15459
Tazarotene
他扎罗汀; AGN 190168
A retinoid prodrug -
GC14396
Ponatinib (AP24534)
普纳替尼; AP24534
An inhibitor of native and mutant Bcr-Abl -
GC12474
AS-605240
5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮
A potent inhibitor of PI3-kinase γ -
GC16868
Sulfasalazine
柳氮磺吡啶; NSC 667219
A prodrug form of 5-aminosalicylic acid -
GC13882
Ranolazine 2HCl
盐酸雷诺嗪; CVT 303 dihydrochloride; RS 43285
A piperazine derivative with cardioprotective activity -
GC18072
Prazosin HCl
哌唑嗪盐酸盐
An α1-adrenergic receptor antagonist -
GC15197
Saracatinib (AZD0530)
塞卡替尼; AZD0530
A dual inhibitor of c-Src and Abl -
GC11473
Irinotecan
伊立替康; (+)-Irinotecan; CPT-11
Irinotecan是一种拓扑异构酶抑制剂,主要用于治疗结直肠癌。Irinotecan可通过与拓扑异构酶 I-DNA 复合物结合,阻止 DNA 链的再连接,并导致 DNA 双链断裂和细胞死亡 。 -
GC14701
Zoledronic Acid
唑来膦酸; Zoledronate; CGP 42446; CGP42446A; ZOL 446
A bisphosphonate that inhibits bone resorption -
GC14238
Brivanib Alaninate (BMS-582664)
1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇L-丙氨酸酯,BMS-582664
A prodrug form of brivanib -
GC12963
NVP-AEW541
AEW541
An IGF-1R inhibitor -
GC17094
Acitretin
阿维A; Ro 10-1670
A retinoid -
GC11692
Brivanib (BMS-540215)
布立尼布; BMS-540215
A VEGFR1, VEGFR2, and FGFR1 inhibitor -
GC10662
WYE-354
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
Potent inhibitor of mTOR in both mTORC1 and mTORC2 -
GC13696
GSK690693
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇
GSK690693 是一种 ATP 竞争性低纳摩尔 Akt 激酶抑制剂,对 Akt1、2 和 3 的 IC50 值分别为 2、13 和 9 nM。 -
GC16421
Cediranib (AZD217)
西地尼布; AZD2171
An inhibitor of VEGF receptor tyrosine kinases